CDKN2A and pancreatic intraductal papillary-mucinous neoplasm: In contrast, TP53, CDKN2A, and SMAD4 mutations are more common with high-grade dysplasia (HGD), supporting their role in risk stratification for IPMN progression to invasive tumors [52, 54].